Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization

Maud Jost; Catherine Maillard; Vincent Lambert; Marc Tjwa; Pierre Blaise; Julie Lecomte; Khalid Bajou; Silvia Blacher; Patrick Motté; Chantal Humblet; Marie Paule Defresne; Marc Thiry; Françis Frankenne; André Gothot; Peter Carmeliet; Jean‐Marie Rakic; Jean‐Michel Foidart; Agnès Noël

Related publications

Article2001

The Plasminogen Activator Inhibitor PAI-1 Controls in Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin

Khalid Bajou, Véronique Masson, Robert D. Gerard, Petra M. Schmitt, Valérie Albert, Michael Praus, Leif R. Lund, Thomas Leth Frandsen, Nils Brünner, Keld Danø, Norbert E. Fusenig, Ulrich H. Weidle, Geert Carmeliet, David J. Loskutoff, D Collen, Peter Carmeliet, Jean‐Michel Foidart, Agnès Noël

Article1997

Small, Dense LDL Particle Concentration Correlates with Plasminogen Activator Inhibitor Type-1 (PAI-1) Activity

Sari Väisänen, Manfred W. Baumstark, Ilkka Penttilä, Claude Bouchard, Pirjo Halonen, Tuomo Rankinen, Aloys Berg, Rainer Rauramaa

Thrombosis and Haemostasis

Article1999

Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1

Agnès Noël, Khalid Bajou, Véronique Masson, Laetitia Devy, Françis Frankenne, Jean‐Marie Rakic, Véronique Lambert, Peter Carmeliet, Jean‐Michel Foidart

Article1998

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization

Khalid Bajou, Agnès Noël, Robert D. Gerard, Véronique Masson, Nils Brünner, Claus Holst‐Hansen, Mihaela Skobe, Norbert E. Fusenig, Peter Carmeliet, D Collen, J.M. Foidart

Article1999

Regular Exercise, Plasminogen Activator Inhibitor-1 (PAI-1) Activity and the 4G/5G Promoter Polymorphism in the PAI-1 Gene

Sari Väisänen, Steve E. Humphries, L A Luong, I Penttilä, Claude Bouchard, R. Rauramaa